|
|
|
20.05.25 - 17:51
|
Mauna Kea Technologies Announces the Availability of Preparatory Documents for the Combined General Meeting of June 5, 2025 and the Instructions for Participation (Business Wire)
|
|
|
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announced the availability of preparatory documents for the Combined General Meeting of June 5, 2025, to be held at 11:00 a.m. at the Company's head office at 9 rue d'Enghien, 75010 - Paris.
Notice of the meeting, including the agenda, proposed resolutions and instructions for participating and voting at the meeting were published in the Bulletin des Annonces Légales Obligatoires (BALO) on April 30, 2025, bulletin n°52, announcement 2501382.
This notice of meeting, together with the documents and information relating to the Combined General Meeting and the single voting form, can be accessed via the Company's website in the "Investors" > “Governance” section of the Shareholders' Meeting area, at the following address https://www.maunakeatech.com/governance/.
Any sha...
|
|
|
07.04.25 - 17:51
|
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital (Business Wire)
|
|
|
Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMF Listing: Euronext Growth Paris
PARIS--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN code: FR0010609263, Ticker: ALMKT
Website: www.maunakeatech.com
Date
Number of shares comprising
the capital in circulation
Total number of voting rights
Gross Total (1)
Net Total (2)
March 31, 2025
68,319,997
69,397,471
69,397,471
Including 200,000 new shares issued during the month as part of the equity financing facility (see press release published on July 25, 2024).
(1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article 223-11 of the General Regulations of the AMF, this number is calculated on the basis of all shares carrying voting rights, including shares without voting rights.
(2) The net number of voting rights (or voting rights "exercisable in General ...
|
|
|
06.02.25 - 17:48
|
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital (Business Wire)
|
|
|
Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMFPARIS--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN code: FR0010609263, Ticker: ALMKT
Website: www.maunakeatech.com
Date
Number of shares comprising
the capital in circulation
Total number of voting rights
Gross Total (1)
Net Total (2)
January 31, 2025
68,119,997
69,201,631
69,201,631
Including 400,000 new shares issued during the month as part of the equity financing facility (see press release published on July 25, 2024).
(1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article 223-11 of the General Regulations of the AMF, this number is calculated on the basis of all shares carrying voting rights, including shares without voting rights.
(2) The net number of voting rights (or voting rights "exercisable in General Meeting") is calculated w...
|
|
|
|
|
21.01.25 - 17:48
|
Mauna Kea Technologies: Half-Year Liquidity Contract Statement for H2 2024 With the Brokerage Firm Gilbert Dupont (Business Wire)
|
|
|
PARIS--(BUSINESS WIRE)--Regulatory News:
Under the liquidity contract between the company MAUNA KEA TECHNOLOGIES (Paris:ALMKT) and the brokerage firm Gilbert Dupont, the following resources appeared on the liquidity account on December 31, 2024:
Number of shares: 0 share
Cash balance: €0
Over the second half of 2024, it has been negotiated a total of:
BUY SIDE
987,283 shares
€349,091.29
1,734 transactions
SELL SIDE
1,071,874 shares
€363,988.03
1,332 transactions
As a reminder, on the half-year statement on June 28, 2024, the following resources were held in the liquidity account:
Number of shares: 84,591 shares
Cash balance: €19,043.09
It is recalled that upon the implementation of the liquidity contract, the following resources were made available:
Number of shares: 7,558 shares
Cash balance: €277,913.78
***
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technol...
|
|
|
15.01.25 - 17:51
|
Mauna Kea Technologies Reports Full Year 2024 Sales and Provides Strategic Update (Business Wire)
|
|
|
Full Year Sales excluding licenses of €5.6m, down 9% YoY amid delayed capital sales and no revenue from JV in China
Two specialized investment banks RM Global and Bucephale Finance mandated to assess all strategic options for the Company
Sustained volume of PPU procedures in ASC vs. 2023 and +48% growth vs. 2022 despite the impact of temporary Medicare reimbursement decrease
CellTolerance® Q4 2024 launch yielding pipeline of more than 40 commercial opportunities
Thanks to significant reduction in operating expenses, the Group anticipates an EBITDA loss between €4.7m and €4.9m1 in 2024
Estimated cash runway through early April 2025, supported by continued cost-cutting initiatives. Ongoing discussions with shareholders and investors to extend horizonPARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Euronext: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces its unaudited sales for the ...
|
|
|
14.01.25 - 17:48
|
Mauna Kea Technologies Announces Its 2025 Financial Calendar (Business Wire)
|
|
|
PARIS & BOSTON--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Euronext Growth: ALMKT), inventor of Cellvizio®, the multidisciplinary probe and needle-based confocal laser endomicroscopy (p/nCLE) platform, today announces the publication of its 2025 Financial Calendar.
Events
Dates*
Fourth Quarter 2024 Sales
January 15, 2025
Full-Year 2024 Financial Results
April 24, 2025
Annual General Meeting
June 5, 2025
Half-Year 2025 Financial Results
October 2, 2025
* Subject to modification. Press releases are published after market closes.
***
About Mauna Kea Technologies
Mauna Kea Technologies is a global medical device company that manufactures and sells Cellvizio®, the real-time in vivo cellular imaging platform. This technology uniquely delivers in vivo cellular visualization which enables physicians to monitor the progression of disease over time, assess point-in-time reactions as they happen in real time, classify indeterminate areas of concern, and guide surgical interventions. The Cellvizio® ...
|
|
|
09.01.25 - 17:48
|
Mauna Kea Technologies: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital (Business Wire)
|
|
|
Article L233-8-II of the Commercial Code
Article 223-16 of the General Regulations of the AMFPARIS--(BUSINESS WIRE)--Regulatory News:
Mauna Kea Technologies (Paris:ALMKT):
Listing: Euronext Growth Paris
ISIN code: FR0010609263, Ticker: ALMKT
Website: www.maunakeatech.com
Date
Number of shares comprising
the capital in circulation
Total number of voting rights
Gross Total (1)
Net Total (2)
December 31, 2024
67,719,997
68,806,000
68,806,000
(1) The gross number of voting rights (or "theoretical" voting rights) serves as the basis for calculating the thresholds. In accordance with Article 223-11 of the General Regulations of the AMF, this number is calculated on the basis of all shares carrying voting rights, including shares without voting rights.
(2) The net number of voting rights (or voting rights "exercisable in General Meeting") is calculated without considering the shares with suspended voting rights. It is published for proper public information in accordance with the AMF recommen...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
